Enter your login e-mail to the account
Search
- Current scientific knowledge about NAFLD/MAFLD during the COVID-19 pandemic and the benefits of essential phospholipids in the treatment of hepatic steatosis
doc. MUDr. Peter Minárik, PhD., MSc, prof. PharmDr. Ján Kyselovič, CSc., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Zuzana Paraličová, PhD., prof. MUDr. Peter Jarčuška, PhD.
(4/2022, Review articles ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Diabesity and liver diseases
MUDr. Marek Rác, PhD.
(2/2021, Topic of the year ) - NONALCOHOLIC FATTY LIVER DISEASE
MUDr. Martin Zima, PhD.
(4-5/2008, Topic ) - Advanced MRI methods for assessment of liver fibrosis and cirhosis
MUDr. René Hako, MUDr. Ivana Haková, doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Pavol Jarčuška, PhD.
(1/2015, Interdisciplinary consilium )
- Komplex metabolic changes in children with obesity
MUDr. Zlatko Marinov, MUDr. Dalibor Pastucha, Ph.D., MBA
(2/2012, Review articles )
- Recent advances in research of Silymarin and its components
Mgr. Jan Soukop, prof. MUDr. Rostislav Večeřa, Ph.D.
(4/2023, Current pharmacotherapy )